ALDH1A3 and neoplasm: Finally, NRAD1 is a novel downstream target of aldehyde dehydrogenase 1A3 (ALDH1A3) and the first lncRNA described to contribute to gene expression changes induced by this CSC marker and mediator of tumor progression [23–31].